Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biocryst Pharmaceuticals Inc (BCRX)  
$4.45 0.03 (0.67%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 189,490,000
Market Cap: 843.23(M)
Last Volume: 2,734,155 Avg Vol: 4,454,926
52 Week Range: $4.13 - $8.81
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  455
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 16,866 495,199
Total Sell Value $0 $0 $135,363 $5,999,241
Total People Sold 0 0 2 9
Total Sell Transactions 0 0 2 14
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 475
  Page 9 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aselage Steve Director   •       •      –    2019-09-01 4 A $2.99 $4,999 D/D 1,672 6,672     -
   Aselage Steve Director   •       •      –    2019-05-22 4 B $3.57 $10,710 D/D 3,000 5,000 2.39     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-17 4 AS $7.45 $18,625 D/D (2,500) 125,176     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-16 4 AS $7.72 $55,970 D/D (7,250) 127,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-16 4 OE $1.42 $6,745 D/D 4,750 134,926     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-15 4 AS $7.92 $57,420 D/D (7,250) 130,176     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-15 4 OE $1.42 $6,745 D/D 4,750 137,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-14 4 AS $7.62 $34,290 D/D (4,500) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-14 4 OE $1.42 $6,390 D/D 4,500 137,176     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-13 4 AS $7.76 $75,660 D/D (9,750) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-13 4 OE $5.51 $53,723 D/D 9,750 142,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-09 4 AS $7.63 $74,393 D/D (9,750) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-09 4 OE $5.51 $53,723 D/D 9,750 142,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-06 4 AS $7.75 $69,750 D/D (9,000) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-06 4 OE $5.51 $49,590 D/D 9,000 141,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-02 4 AS $7.30 $56,575 D/D (7,750) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-05-02 4 OE $5.51 $42,703 D/D 7,750 140,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-04-04 4 AS $8.81 $66,075 D/D (7,500) 132,676     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-04-04 4 OE $5.51 $41,325 D/D 7,500 140,176     -
   Aselage Steve Director   •       •      –    2019-03-12 4 B $8.30 $16,600 D/D 2,000 2,000 2.39     -
   Babu Yarlagadda S Senior VP - Drug Discovery   •       •      –    2019-01-31 4 D $8.68 $81,479 D/D (9,387) 130,587     -
   Babu Yarlagadda S Senior VP - Drug Discovery   •       •      –    2019-01-31 4 OE $1.20 $38,249 D/D 31,874 132,272     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-01-28 4 AS $9.85 $49,250 D/D (5,000) 128,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2019-01-28 4 OE $5.45 $27,250 D/D 5,000 133,426     -
   Powell Lynne Senior VP - CCO   •       •      –    2019-01-28 4 AS $9.88 $59,340 D/D (6,000) 0     -
  475 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us